| HLA-B* 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol SI Hung, WH Chung, LB Liou, CC Chu, M Lin, HP Huang, YL Lin, JL Lan, ... Proceedings of the National Academy of Sciences 102 (11), 4134-4139, 2005 | 1547 | 2005 |
| Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study SH Kardaun, P Sekula, L Valeyrie‐Allanore, Y Liss, CY Chu, D Creamer, ... British Journal of Dermatology 169 (5), 1071-1080, 2013 | 1010 | 2013 |
| Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double … E Guttman-Yassky, HD Teixeira, EL Simpson, KA Papp, AL Pangan, ... The Lancet 397 (10290), 2151-2168, 2021 | 434 | 2021 |
| Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction JW Tjiu, JS Chen, CT Shun, SJ Lin, YH Liao, CY Chu, TF Tsai, HC Chiu, ... Journal of Investigative Dermatology 129 (4), 1016-1025, 2009 | 400 | 2009 |
| Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases YC Chen, HC Chiu, CY Chu Archives of dermatology 146 (12), 1373-1379, 2010 | 390 | 2010 |
| Common risk allele in aromatic antiepileptic-drug induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese SI Hung, WH Chung, ZS Liu, CH Chen, MS Hsih, RC Hui, CY Chu, ... Pharmacogenomics 11 (3), 349-356, 2010 | 373 | 2010 |
| Abrocitinib versus placebo or dupilumab for atopic dermatitis T Bieber, EL Simpson, JI Silverberg, D Thaçi, C Paul, AE Pink, Y Kataoka, ... New England Journal of Medicine 384 (12), 1101-1112, 2021 | 367 | 2021 |
| Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system YT Cho, CW Yang, CY Chu International Journal of Molecular Sciences 18 (6), 1243, 2017 | 317 | 2017 |
| Ligelizumab for chronic spontaneous urticaria M Maurer, AM Giménez-Arnau, G Sussman, M Metz, DR Baker, A Bauer, ... New England Journal of Medicine 381 (14), 1321-1332, 2019 | 265 | 2019 |
| MicroRNA-519c suppresses hypoxia-inducible factor-1α expression and tumor angiogenesis ST Cha, PS Chen, G Johansson, CY Chu, MY Wang, YM Jeng, SL Yu, ... Cancer research 70 (7), 2675-2685, 2010 | 258 | 2010 |
| Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways SH Jee, CY Chu, HC Chiu, YL Huang, WL Tsai, YH Liao, ML Kuo Journal of investigative dermatology 123 (6), 1169-1175, 2004 | 227 | 2004 |
| Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan YC Chen, CY Chang, YT Cho, HC Chiu, CY Chu Journal of the American Academy of Dermatology 68 (3), 459-465, 2013 | 208 | 2013 |
| miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans PS Chen, JL Su, ST Cha, WY Tarn, MY Wang, HC Hsu, MT Lin, CY Chu, ... The Journal of clinical investigation 121 (9), 2011 | 195 | 2011 |
| IL‐6 induces AGS gastric cancer cell invasion via activation of the c‐Src/RhoA/ROCK signaling pathway MT Lin, BR Lin, CC Chang, CY Chu, HJ Su, ST Chen, YM Jeng, ML Kuo International journal of cancer 120 (12), 2600-2608, 2007 | 170 | 2007 |
| Connective tissue growth factor (CTGF) and cancer progression CY Chu, CC Chang, E Prakash, ML Kuo Journal of biomedical science 15, 675-685, 2008 | 154 | 2008 |
| Efficacy and safety of upadacitinib in patients with moderate to severe atopic dermatitis: analysis of follow-up data from the measure up 1 and measure up 2 randomized clinical … EL Simpson, KA Papp, A Blauvelt, CY Chu, HC Hong, N Katoh, ... JAMA dermatology 158 (4), 404-413, 2022 | 153 | 2022 |
| Sequelae in 145 patients with drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on … Y Kano, M Tohyama, M Aihara, S Matsukura, H Watanabe, H Sueki, ... The Journal of Dermatology 42 (3), 276-282, 2015 | 145 | 2015 |
| Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features YT Cho, JW Lin, YC Chen, CY Chang, CH Hsiao, WH Chung, CY Chu Journal of the American Academy of Dermatology 70 (3), 539-548, 2014 | 143 | 2014 |
| Consensus guidelines for the management of atopic dermatitis: An A sia–P acific perspective D Rubel, T Thirumoorthy, RW Soebaryo, SCK Weng, TM Gabriel, ... The Journal of dermatology 40 (3), 160-171, 2013 | 141 | 2013 |
| Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians CB Chen, YH Hsiao, T Wu, MS Hsih, W Tassaneeyakul, TP Jorns, ... Neurology 88 (1), 78-86, 2017 | 132 | 2017 |
